State Duma Adopted Bill on Price for VED

| By | Pricing, Russian Pharma, VED
0
101

The State Duma adopted a bill to control the prices of vital and essential medicines in a final third reading, according to the information published on the website of the lower house of Russian parliament.

The draft law stipulates binding reregistration of producers’ maximum sale prices for vital and essential drugs if their price has reduced in a producing country and in the states where these medicines have been registered.

The bill also envisages that the producer’s registered maximum sale price for such drugs may be rerecorded increasingly not more frequently than once a year.

Amendments are proposed to the law on medicine circulation.

SOURCE: RAPSI
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.